Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response
Keywords: FBP; Folate binding protein; GM-CSF; Granulocyte macrophage colony stimulating factor; CTL; cytotoxic T lymphocyte; PVS; Primary Vaccine Series; DTH; delayed-type hypersensitivity; R0; assessment pre-PVS; RC1; assessment 1â¯month post-PVS; RC6; assessmen